Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 1/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | THRB | P10828 | 1/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.55 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.55 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.55 |
| ▸ | THPO | P40225 | 1/20 | 0.55 |
| ▸ | RECQL | P46063 | 1/20 | 0.55 |
| ▸ | BLM | P54132 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.54 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.54 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.47 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.44 |
| ▸ | FNTA | P49354 | 5/20 | 0.43 |
| ▸ | FNTB | P49356 | 5/20 | 0.43 |
| ▸ | PGGT1B | P53609 | 3/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5579254 | 1.00 | ACE (0.60) | ACEKDM4EMAPTTHRBALOX15 | |
| SCHEMBL296932 | 1.00 | ACE (0.60) | ACEKDM4EMAPTTHRBALOX15 | |
| SCHEMBL29663240 | 1.00 | ACE (0.60) | ACEKDM4EMAPTTHRBALOX15 | |
| SCHEMBL5665364 | 0.96 | ACE (0.56) | ACEKDM4EMAPTTHRBALOX15 | |
| SCHEMBL16770240 | 0.96 | ACE (0.56) | ACEKDM4EMAPTTHRBALOX15 | |
| SCHEMBL22969994 | 0.96 | ACE (0.56) | ACEKDM4EMAPTTHRBALOX15 | |
| SCHEMBL7072854 | 0.96 | ACE (0.56) | ACEKDM4EMAPTTHRBALOX15 | |
| SCHEMBL6809797 | 0.96 | ACE (0.56) | ACEKDM4EMAPTTHRBALOX15 | |
| SCHEMBL29461530 | 0.91 | ACE (0.51) | ACEKDM4EMAPTTHRBALOX15 | |
| SCHEMBL30011698 | 0.91 | ACE (0.51) | ACEKDM4EMAPTTHRBALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260132547-A1 | NOVEL PHAGE LIBRARIES OF BICYCLIC PEPTIDES | THE TRUSTEES OF BOSTON COLLEGE (US) | 2026-05-14 | — | — | US | claimed |
| US-20260098059-A1 | COMPOSITIONS AND METHODS FOR TREATING ENDOMETRIOSIS | ENDOMET BIOSCIENCES INC (US) | 2026-04-09 | — | — | US | claimed |
| EP-4720089-A1 | COMPOSITIONS AND METHODS FOR IMAGING AND TREATING ENDOMETRIOSIS | Endomet Biosciences, Inc. (US) | 2026-04-08 | — | — | EP | claimed |
| US-20260007756-A1 | COMPOUND AND USE THEREOF | COHERENT BIOPHARMA SUZHOU LTD (CN) | 2026-01-08 | — | — | US | claimed |
| US-12473332-B2 | Modified peptides and associated methods of use | ADVANCED TECH FOR NOVEL THERAPEUTICS LLC (US) | 2025-11-18 | — | — | US | claimed |
| US-12359001-B2 | Method for producing polypeptide hetero-oligomer | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2025-07-15 | — | — | US | claimed |
| WO-2025092703-A1 | PHOTOSENSITIZER CONJUGATE COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF | 同宜医药（苏州）有限公司 | 2025-05-08 | — | — | WO | claimed |
| CN-119909192-A | Photosensitizer conjugate compound, pharmaceutical composition and application thereof | 同宜医药（苏州）有限公司 | 2025-05-02 | — | — | CN | claimed |
| CN-118759175-B | Immunoglobulin G4 subtype detection kit and preparation method thereof | 浙江伊利康生物技术有限公司 | 2025-03-21 | — | — | CN | claimed |
| US-12247320-B2 | Multivalent glycopeptides that tightly bind to carbohydrate-binding monoclonal antibody family PGT128 | BRANDEIS UNIVERSITY (US) | 2025-03-11 | — | — | US | claimed |
| WO-2022084739-A1 | COMPOUNDS AND METHODS FOR THE TREATMENT OF OCULAR DISORDERS | Azura Ophthalmics Ltd. (IL) | 2022-04-28 | — | — | WO | claimed |
| CN-114401998-A | NKG2D fusion protein and use thereof | 诺华股份有限公司 | 2022-04-26 | — | — | CN | claimed |
| CN-114288426-A | Application of icatibant and derivatives thereof in preparation of tumor diagnosis and/or treatment reagents | 江西中医药大学 | 2022-04-08 | — | — | CN | claimed |
| US-20220090055-A1 | MULTIVALENT GLYCOPEPTIDES THAT TIGHTLY BIND TO CARBOHYDRATE-BINDING MONOCLONAL ANTIBODY FAMILY PGT128 | BRANDEIS UNIVERSITY | 2022-03-24 | — | — | US | claimed |
| CN-114177314-A | Application of thymopentin and derivatives thereof in preparation of tumor diagnosis and/or treatment reagent | 江西中医药大学 | 2022-03-15 | — | — | CN | claimed |
| CN-114174316-A | Modified peptides and related methods of use | 新颖疗法的先进技术有限责任公司 | 2022-03-11 | — | — | CN | claimed |
| US-7875268-B2 | The use of certain dimercaptoamides as reducing agents, 2-mercapto-N-(2-mercaptoethyl)acetamide, results in curling that is satisfactoryin terms of intensity and in terms of hold over time; less substantial degradation of the hair fiber compared with the reducing agents of the prior art; permanent waves | L'OREAL S.A. (FR) | 2011-01-25 | — | — | US | claimed |
| EP-1584615-B1 | Use of dimercaptoamides for permanently deforming of keratinic fibres | OREAL (FR) | 2008-05-28 | — | — | EP | claimed |
| US-20060013784-A1 | Novel dimercaptoamides, compositions comprising them as reducing agents, and processes for permanently reshaping keratin fibers therewith | L'OREAL S.A. (FR) | 2006-01-19 | — | — | US | claimed |
| EP-1584615-A1 | Use of dimercaptoamides for permanently deforming of keratinic fibres | L'OREAL (FR) | 2005-10-12 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060013784-A1 | Novel dimercaptoamides, compositions comprising them as reducing agents, and processes for permanently reshaping keratin fibers therewith | KRT18, CKAP4, S100A4 | ACE 3872/4885KDM4E 488/4885MAPT 998/4885 |
| US-20260132547-A1 | NOVEL PHAGE LIBRARIES OF BICYCLIC PEPTIDES | PTMS, QPCTL, CMBL | ACE 2189/4885KDM4E 2516/4885MAPT 3021/4885 |
| US-20260007756-A1 | COMPOUND AND USE THEREOF | FOLH1, TRPV6, FOLR1 | ACE 2388/4885KDM4E 3194/4885MAPT 754/4885 |
| US-12247320-B2 | Multivalent glycopeptides that tightly bind to carbohydrate-binding monoclonal antibody family PGT128 | CSGALNACT1, STT3A, GALNT14 | ACE 3424/4885KDM4E 4037/4885MAPT 821/4885 |
| US-20260098059-A1 | COMPOSITIONS AND METHODS FOR TREATING ENDOMETRIOSIS | NR1H2, NR1H3, CTNND1 | ACE 4883/4885KDM4E 168/4885MAPT 4146/4885 |
| US-20220090055-A1 | MULTIVALENT GLYCOPEPTIDES THAT TIGHTLY BIND TO CARBOHYDRATE-BINDING MONOCLONAL ANTIBODY FAMILY PGT128 | CSGALNACT1, STT3A, GALNT14 | ACE 3424/4885KDM4E 4037/4885MAPT 821/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.